ライフサイエンスコーパス: topical antibiotic

1 nd later as addition after 4 or more days of topical antibiotics.

2 out the use of preinjection or postinjection topical antibiotics.

3 trials comparing oral antibiotic agents with topical antibiotics.

4 vitreal injections with use of postinjection topical antibiotics.

5 ive topical, intracameral, and postoperative topical antibiotics.

6 %) patients received 1 or more postoperative topical antibiotics.

7 ing and may contribute to overprescribing of topical antibiotics.

8 30.3% (n = 10/33) administered preoperative topical antibiotics.

9 he optimal treatment of discharge in CSOM is topical antibiotics.

10 ve-free lubricant eye drops and prophylactic topical antibiotics.

11 i-infectives: -36%, 95% CI: -6% to -56%; and topical antibiotics: -18%, 95% CI: -5% to -29%).

12 Topical antibiotics (89%) were the most commonly prescri

13 Treatments such as systemic or topical antibiotic administration, skin grafting, and nu

14 met, we added the mandatory use of fortified topical antibiotics after cultures are obtained.

15 re and antibiogram results, intracameral and topical antibiotic agent, and dose.

16 e gentamicin-collagen sponge, an implantable topical antibiotic agent, is approved for surgical impla

17 global clinical trials of retapamulin, a new topical antibiotic agent.

18 ost-cataract extraction endophthalmitis than topical antibiotic alone.

19 herapies, on average, may not be superior to topical antibiotics alone for treatment of bacterial ker

20 Topical antibiotics alone or in combination may be among

21 Standard clinical practice is to prescribe a topical antibiotic, although the evidence to support thi

22 aocular lens (IOL) implant and postoperative topical antibiotic and steroid.

23 otal of 584 children were randomized (300 to topical antibiotics and 284 to a placebo), and the use o

24 0.05% of 11565 injections) in eyes receiving topical antibiotics and 3 cases (0.02% of 17208 injectio

25 She was treated with topical antibiotics and achieved satisfactory recovery.

26 Ophthalmologists continue to choose topical antibiotics and corticosteroids more frequently

27 Ophthalmologists are choosing topical antibiotics and corticosteroids more frequently

28 years had been discontinuously treated with topical antibiotics and corticosteroids without any evid

29 acute conjunctivitis fill prescriptions for topical antibiotics and factors associated with antibiot

30 vs placebo) as addition after 2 to 3 days of topical antibiotics and later as addition after 4 or mor

31 Infections were treated with oral or topical antibiotics and resolved without complication, e

32 rd protocol with intravitreal, systemic, and topical antibiotics and systemic steroids.

33 The prescription of eye topical antibiotics and the frequency of surgical site i

34 All patients were treated with topical antibiotics, and 98% were treated with topical s

35 Although topical antibiotic application continues to be a controv

36 Although topical antibiotics are often prescribed for treating ac

37 e rapidly become the standard of care in the topical antibiotic arena.

38 scribing prophylactic intravenous, oral, and topical antibiotics as well as factors that influence su

39 ts always use a lid speculum, 21% administer topical antibiotics before injection, 36% wear a mask, 7

40 Administering postoperative topical antibiotics can be distressing to children, cost

41 effect of topical povidone-iodine 1.25% and topical antibiotics commonly available in the developing

42 ho were or were not prescribed postoperative topical antibiotics comprised the study and control grou

43 Topical antibiotics decrease the duration of bacterial c

44 Reducing skin microbiota via cage changes or topical antibiotics decreased WIHN.

45 The prescription of prophylactic topical antibiotics did not decrease rates of surgical s

46 ine 5% alone in the absence of postinjection topical antibiotics does not appear to promote bacterial

47 Using postinjection topical antibiotic drops does not reduce the risk of end

48 Use of topical antibiotics either before or after injection doe

49 tial disadvantages, the use of postoperative topical antibiotics following strabismus surgery may not

50 vidone-iodine 1.25% ophthalmic solution with topical antibiotics for treatment of bacterial keratitis

51 t povidone-iodine and rates with and without topical antibiotics from Diabetic Retinopathy Clinical R

52 vidone-iodine and consideration to eliminate topical antibiotics from injection procedures seems warr

53 ure-proven endophthalmitis alone, the use of topical antibiotics, given immediately or for 5 days aft

54 d endophthalmitis is greater with the use of topical antibiotics, given immediately or for 5 days aft

55 New topical antibiotics have also come to the market, provid

56 ation of adjunct therapy, ozone delivery and topical antibiotics have been integrated into a single a

57 Despite receiving systemic and topical antibiotics, her clinical symptoms and signs wor

58 though using the combination of systemic and topical antibiotics, his clinical status progressively d

59 ile conjunctivitis, where recorded, included topical antibiotics in 523 (90.8%) and simple observatio

60 in-collagen sponge, a surgically implantable topical antibiotic, is currently approved in 54 countrie

61 ction model, highlighting its potential as a topical antibiotic lead.

62 Topical antibiotics may be among the least effective.

63 in areas of the world where use of effective topical antibiotics may not be an option.

64 In resource-limited settings where topical antibiotics might not be available, topical anti

65 y directly delivering the combination of the topical antibiotic minocycline and the retinoid tazarote

66 ial plastic surgery, patients treated with a topical antibiotic ointment showed a lower risk of surgi

67 of ocular-associated bacteria, the impact of topical antibiotics on corneal CD11c+ cell populations d

68 udy is to assess the effect of postoperative topical antibiotics on the rate of surgical site infecti

69 Topical antibiotics or cohousing of ft/ft mice with unaf

70 Topical antibiotics, oral acyclovir, low-dose topical st

71 On bivariate analysis, the use of oral and topical antibiotics over the preceding 6 months was stro

72 % of 17208 injections) in eyes not receiving topical antibiotics (P = .17).

73 were performed (57 654 injections during the topical antibiotic period, 24 617 during the transition

74 During the 28-month topical antibiotic period, there were 28 cases of suspec

75 Not all strabismus surgeons use prophylactic topical antibiotics postoperatively because they may be

76 calculating the proportion filling 1 or more topical antibiotic prescription within 14 days of initia

77 te conjunctivitis, 198 462 (58%) filled >/=1 topical antibiotic prescriptions; 38 774 filled prescrip

78 chemicals as the most common causes: nickel, topical antibiotics, preservative chemicals, fragrances

79 The usefulness of topical antibiotic prophylaxis for routine oculofacial p

80 General use of preoperative topical antibiotic prophylaxis is not cost-effective com

81 Preoperative topical antibiotic prophylaxis vs no-prophylaxis costs a

82 following cataract surgery for preoperative topical antibiotic prophylaxis vs no-prophylaxis was 0.0

83 han 5.5% or if the price of the preoperative topical antibiotic prophylaxis was less than $0.75.

84 Three strategies of topical antibiotic prophylaxis were used by the respecti

85 Preoperative topical antibiotic prophylaxis, however, would be cost-e

86 ncy of infection with and without the use of topical antibiotic prophylaxis.

87 Topical antibiotics remain the best treatment for bacter

88 overage with hourly fortified broad-spectrum topical antibiotic therapy.

89 a requires systemic treatment in addition to topical antibiotic therapy.

90 zes gaseous ozone as an adjunct therapy with topical antibiotics through a novel dressing with drug-e

91 topical retinoid should be used instead of a topical antibiotic to minimise the impact of resistance.

92 recent review found all commonly prescribed topical antibiotics to be equally effective.

93 ice has shown that the timely application of topical antibiotics to the skin at the tick bite site co

94 acrimal canaliculitis resistant to prolonged topical antibiotic treatment in a 65-year-old woman with

95 eutralization, signal-blocking reagents, and topical antibiotic treatment to explore the inflammatory

96 ith non-Nocardia keratitis and those with no topical antibiotic use before enrollment.

97 h non-Nocardia keratitis and those having no topical antibiotic use before the SCUT enrollment showed

98 Topical antibiotic use was associated with a trend towar

99 Topical antibiotic use was common in all regions (85.2%)

100 olicy, use of subconjunctival lidocaine, and topical antibiotic use were not statistically significan

101 Topical antibiotic was not shown to add to the effective

102 iotics and 284 to a placebo), and the use of topical antibiotics was associated with a significant re

103 Exclusion of topical antibiotics was not associated with a higher ris

104 ial and systematic review and meta-analysis, topical antibiotics were associated with significantly s

105 tion was compared with a 9-month period when topical antibiotics were not prescribed.

106 A 28-month period when topical antibiotics were prescribed after intravitreal i

107 mized controlled trials (RCTs) that compared topical antibiotics with placebo.